Respiratory syncytial virus interaction with human airway epithelium

Trends in Microbiology

Volumn 21, Issue 5, 2013, Pages 238-244

  Villenave, Remi ^a   Shields, Michael D ^a,b   Power, Ultan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Cytopathogenesis; Human airway epithelium; Respiratory syncytial virus; Well differentiated primary airway epithelium cultures

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PALIVIZUMAB; RANTES; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

CILIARY DYSKINESIA; COCULTURE; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; EPITHELIUM CELL; HUMAN; INNATE IMMUNITY; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; VIRAL BRONCHIOLITIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS SHEDDING; WELL DIFFERENTIATED PRIMARY AIRWAY EPITHELIAL CELL;

ANIMALS; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84877115919     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.02.004     Document Type: Review

References (80)

1. Collins P.L., et al. Respiratory syncytial virus. Virology 2001, 1443-1485. Raven Press. 4th edn. D. Knipe (Ed.).
2. Hall C.B. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 2001, 344:1917-1928.
3. Glezen W.P., et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 1986, 140:543-546.
4. Village E.G. From the American Academy of Pediatrics: Policy statements - Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009, 124:1694-1701.
5. Thorburn K., et al. Mortality and morbidity of nosocomial respiratory syncytial virus (RSV) infection in ventilated children - a ten year perspective. Minerva Anestesiol. 2012, 78:782.
6. Stein R.T., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999, 354:541-545.
7. Sigurs N., et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 2005, 171:137-141.
8. Henderson F.W., et al. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 1979, 300:530-534.
9. Hall C.B., et al. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 1991, 163:693-698.
10. Falsey A.R., et al. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 2005, 352:1749-1759.
11. Touzelet O., Power U. Cellular and molecular characteristics of RSV-induced disease in humans. Human Respiratory Syncytial Virus Infection 2011, 97-122. In Tech. R. Bernhard (Ed.).
12. Welliver T.P., et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 2007, 195:1126-1136.
13. McNamara P.S., et al. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2005, 191:1225-1232.
14. Sheeran P., et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr. Infect. Dis. J. 1999, 18:115-122.
15. Chanock R., et al. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am. J. Hyg. 1957, 66:281-290.
16. Stokes K.L., et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J. Virol. 2011, 85:5782-5793.
17. Köndgen S., et al. Pandemic human viruses cause decline of endangered great apes. Curr. Biol. 2008, 18:260-264.
18. Szentiks C.A., et al. Lethal pneumonia in a captive juvenile chimpanzee (Pan troglodytes) due to human-transmitted human respiratory syncytial virus (HRSV) and infection with Streptococcus pneumoniae. J. Med. Primatol. 2009, 38:236-240.
19. Becker S., et al. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1992, 6:369-374.
20. Shigeta S., et al. The cell to cell infection of respiratory syncytial virus in HEp-2 monolayer cultures. J. Gen. Virol. 1968, 3:129-131.
21. Kwilas S., et al. Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. J. Virol. 2009, 83:10710-10718.
22. Malykhina O., et al. A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression. J. Virol. 2011, 85:4792-4801.
23. Villenave R., et al. Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. Virol. J. 2011, 8:43.
24. Whitcutt M.J., et al. A biphasic chamber system for maintaining polarity of differentiation of cultured respiratory tract epithelial cells. In Vitro Cell. Dev. Biol. 1988, 24:420-428.
25. Gray T.E., et al. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 1996, 14:104-112.
26. Zhang L., et al. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 2002, 76:5654-5666.
27. Parker J., et al. A 3-D well-differentiated model of pediatric bronchial epithelium demonstrates unstimulated morphological differences between asthmatic and nonasthmatic cells. Pediatr. Res. 2010, 67:17-22.
28. Villenave R., et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5040-5045.
29. Dvorak A., et al. Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome?. Am. J. Respir. Cell Mol. Biol. 2011, 44:465-473.
30. Pezzulo A.A., et al. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L25-L31.
31. Wright P., et al. Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract. J. Virol. 2005, 79:8651-8654.
32. Graham B.S., et al. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 2000, 48:237-247.
33. McNamara P.S., Smyth R.L. The pathogenesis of respiratory syncytial virus disease in childhood. Br. Med. Bull. 2002, 61:13-28.
34. Zhang L., et al. Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus. Virology 2011, 421:67-77.
35. Wright C., et al. A monoclonal antibody pool for routine immunohistochemical detection of human respiratory syncytial virus antigens in formalin-fixed, paraffin-embedded tissue. J. Pathol. 1997, 182:238-244.
36. Johnson J.E., et al. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 2007, 20:108-119.
37. Aherne W., et al. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 1970, 23:7-18.
38. Tristram D.A., et al. Respiratory syncytial virus and human bronchial epithelium. Arch. Otolaryngol. Head Neck Surg. 1998, 124:777-783.
39. Mata M., et al. Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine. PLoS ONE 2012, 7:e48037.
40. Buckingham S.C., et al. Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants. Pediatr. Infect. Dis. J. 2000, 19:113.
41. DeVincenzo J.P., et al. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J. Infect. Dis. 2005, 191:1861-1868.
42. Fletcher J.N., et al. Respiratory syncytial virus genotypes and disease severity among children in hospital. Arch. Dis. Child. 1997, 77:508-511.
43. Hall C.B., et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J. Infect. Dis. 1990, 162:1283-1290.
44. Martinello R.A., et al. Correlation between respiratory syncytial virus genotype and severity of illness. J. Infect. Dis. 2002, 186:839-842.
45. Savón C., et al. Respiratory syncytial virus group A and B genotypes and disease severity among Cuban children. Arch. Med. Res. 2006, 37:543-547.
46. Welliver T.P., et al. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. Pediatr. Infect. Dis. J. 2008, 27:S92-S96.
47. Jones A., et al. Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis. Eur. Respir. J. 2002, 20:651-657.
48. Everard M.L., et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch. Dis. Child. 1994, 71:428-432.
49. McNamara P.S., et al. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch. Dis. Child. 2003, 88:922-926.
50. Smith P.K., et al. Leucocyte populations in respiratory syncytial virus-induced bronchiolitis. J. Paediatr. Child Health 2001, 37:146-151.
51. McNamara P.S., et al. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur. Respir. J. 2004, 23:106-112.
52. Arnold R., Konig W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J. Immunol. 2005, 174:7359-7367.
53. Garofalo R.P., et al. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2001, 184:393-399.
54. Laham F.R., et al. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J. Infect. Dis. 2004, 189:2047-2056.
55. Murai H., et al. IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection. Allergol. Int. 2007, 56:157-163.
56. Noah T.L., et al. Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin. Immunol. 2002, 104:86-95.
57. Roe M.F.E., et al. Changes in helper lymphocyte chemokine receptor expression and elevation of IP-10 during acute respiratory syncytial virus infection in infants. Pediatr. Allergy Immunol. 2011, 22:229-234.
58. Van Benten I.J., et al. RSV-induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response. J. Med. Virol. 2003, 71:290-297.
59. Bermejo-Martin J.F., et al. Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. Eur. Cytokine Netw. 2007, 18:162-167.
60. Noah T.L., Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin. Immunol. 2000, 97:43-49.
61. Taylor C.E., et al. Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity. Arch. Dis. Child. 1989, 64:1656-1660.
62. Isaacs D. Production of interferon in respiratory syncytial virus bronchiolitis. Arch. Dis. Child. 1989, 64:92-95.
63. Scagnolari C., et al. Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin. Vaccine Immunol. 2009, 16:816-823.
64. Oshansky C.M., et al. Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. J. Infect. Dis. 2010, 201:1201-1207.
65. Mellow T.E., et al. The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium. Exp. Lung Res. 2004, 30:43-57.
66. Das S., et al. Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells. Laryngoscope 2005, 115:764-768.
67. Chang M.M., et al. A novel mechanism of retinoic acid-enhanced interleukin-8 gene expression in airway epithelium. Am. J. Respir. Cell Mol. Biol. 2000, 22:502-510.
68. Okabayashi T., et al. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res. 2011, 160:360-366.
69. Vaughan M.B., et al. A three-dimensional model of differentiation of immortalized human bronchial epithelial cells. Differentiation 2006, 74:141-148.
70. Ramirez R.D., et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 2004, 64:9027-9034.
71. Farwell D.G., et al. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am. J. Pathol. 2000, 156:1537-1547.
72. H17 cells. J. Allergy Clin. Immunol. 2009, 123:588-595.
73. Nagarkar D.R., et al. Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin. J. Allergy Clin. Immunol. 2012, 130:225-232.
74. Obregon C., et al. Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNF-alpha-mediated pathway. Am. J. Pathol. 2009, 175:696-705.
75. Blank F., et al. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am. J. Respir. Cell Mol. Biol. 2007, 36:669-677.
76. Horvath K.M., et al. Epithelial cells from smokers modify dendritic cell responses in the context of influenza infection. Am. J. Respir. Cell Mol. Biol. 2011, 45:237-245.
77. Nicholls J.M., et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir. Res. 2007, 8:73.
78. Abu-Harb M., et al. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur. Respir. J. 1999, 14:139-143.
79. Matsuda K., et al. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin. Vaccine Immunol. 1995, 2:322-324.
80. Hornsleth A., et al. Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Pediatr. Infect. Dis. J. 1998, 17:1114-1121.